Page 29 - Neurology Department News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Does Post-Stroke Care Need to Improve Clinical Endpoints?

The question of whether a multidisciplinary post-stroke care program should be judged on its ability to prevent major cardiovascular events at 1 year was raised after a trial showed no benefit.

Region flamandeLudwigshafen am rheinRheinland pfalzChristopherj schwarzbachStadt ludwigshafenRobin lemmensArthur lieszNeurology departmentNational institute of health stroke scaleEuropean stroke organisation conferenceInstitute for strokeDepartment of neurosciencesUniversity hospitalDementia researchMedscape medical newsModified rankin scale

Clene s (CLNN) CNM-Au8 Shows Statistically Significant Difference in Plasma Neurofilament Light (NfL) levels in the HEALEY ALS Platform Trial

Clene s (CLNN) CNM-Au8 Shows Statistically Significant Difference in Plasma Neurofilament Light (NfL) levels in the HEALEY ALS Platform Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSalt lake cityContactignacio guerrero rosBenjamin greenbergDavid schullRob etheringtonSeanm healeyEl escorialContactkevin gardnerRusso partnersSecurities exchangeClene nanomedicine incClene incNeurology departmentClene nanomedicineMonth plasma nfl biomarker findings

Clene s CNM-Au8® Shows Statistically Significant Difference in Plasma Neurofilament Light (NfL) levels in the HEALEY ALS Platform Trial

Clene s CNM-Au8® Shows Statistically Significant Difference in Plasma Neurofilament Light (NfL) levels in the HEALEY ALS Platform Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSalt lake cityContactkevin gardnerEl escorialSeanm healeyRob etheringtonDavid schullBenjamin greenbergContactignacio guerrero rosClene incNeurology departmentSecurities exchangeClene nanomedicine incRusso partnersClene nanomedicineMonth plasma nfl biomarker findings

Clene s CNM-Au8® Shows Statistically Significant Difference in Plasma Neurofilament Light (NfL) levels in the HEALEY ALS Platform Trial

CNM-Au8® treatment demonstrated significantly reduced plasma neurofilament light chain levels compared to placebo at 24 weeks Clene plans to discuss the totality of the survival and time-to-event. | June 16, 2023

United statesSalt lake cityEl escorialDavid schullRob etheringtonIgnacio guerrero rosKevin gardnerSeanm healeyBenjamin greenbergSecurities exchangeNeurology departmentRusso partnersGlobenewswire incClene nanomedicine incClene incMonth plasma nfl biomarker findings

Clene s CNM-Au8® Shows Statistically Significant Difference in Plasma Neurofilament Light (NfL) levels in the HEALEY ALS Platform Trial

Clene s CNM-Au8® Shows Statistically Significant Difference in Plasma Neurofilament Light (NfL) levels in the HEALEY ALS Platform Trial
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Salt lake cityUnited statesIgnacio guerrero rosRob etheringtonKevin gardnerBenjamin greenbergEl escorialDavid schullSeanm healeyClene incSecurities exchangeNeurology departmentClene nanomedicine incRusso partnersShows statistically significant differencePlasma neurofilament light